| __timestamp | Pharming Group N.V. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 4042025 | 2999000 |
| Thursday, January 1, 2015 | 5279557 | 10393000 |
| Friday, January 1, 2016 | 8073913 | 15994000 |
| Sunday, January 1, 2017 | 44864073 | 26975000 |
| Monday, January 1, 2018 | 53488904 | 39509000 |
| Tuesday, January 1, 2019 | 65896361 | 48869000 |
| Wednesday, January 1, 2020 | 69968267 | 42510000 |
| Friday, January 1, 2021 | 92047281 | 46105000 |
| Saturday, January 1, 2022 | 131819000 | 50513000 |
| Sunday, January 1, 2023 | 87501000 | 51292000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, Pharming Group N.V. and Wave Life Sciences Ltd. have shown distinct trends in their SG&A efficiency. From 2014 to 2023, Pharming Group N.V. saw a staggering increase of over 2,000% in SG&A expenses, peaking in 2022. In contrast, Wave Life Sciences Ltd. experienced a more moderate rise of approximately 1,600% during the same period. Notably, Pharming's expenses surged in 2017, coinciding with strategic expansions, while Wave Life Sciences maintained a steadier growth trajectory. This analysis highlights the importance of strategic financial management in sustaining growth and competitiveness in the biotech sector. As these companies continue to innovate, their ability to manage SG&A expenses will be pivotal in determining their long-term success.
Eli Lilly and Company and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Pharming Group N.V.
Comparing SG&A Expenses: Novartis AG vs Pharming Group N.V. Trends and Insights
Comparing SG&A Expenses: Alnylam Pharmaceuticals, Inc. vs Pharming Group N.V. Trends and Insights
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Pharming Group N.V.
Comparing SG&A Expenses: Pharming Group N.V. vs Catalyst Pharmaceuticals, Inc. Trends and Insights
Breaking Down SG&A Expenses: Pharming Group N.V. vs BioCryst Pharmaceuticals, Inc.
Lantheus Holdings, Inc. and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and Wave Life Sciences Ltd.
Selling, General, and Administrative Costs: Protagonist Therapeutics, Inc. vs Wave Life Sciences Ltd.
Mesoblast Limited and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Wave Life Sciences Ltd. or MiMedx Group, Inc.